Targeting the Sialic acid/Siglec axis: opportunities and challenges in colorectal cancer immunotherapy. [PDF]
Wang T, Rong C, Sun G, Wang Y.
europepmc +1 more source
Systematic pathway engineering of Escherichia coli for enhanced 3'-sialyllactose production. [PDF]
Wu Y +8 more
europepmc +1 more source
A novel autopolysialylation activity of the ganglioside sialyltransferase ST8Sia5 regulates its secretion and enzyme activity. [PDF]
Sakamoto F +5 more
europepmc +1 more source
Transcriptomic analysis of genes in bladder cancer patients with resistance to neoadjuvant chemoimmunotherapy. [PDF]
Chen C +9 more
europepmc +1 more source
The glycobiology of prostate cancer: an update. [PDF]
Hodgson K +10 more
europepmc +1 more source
Aberrant sialylation in cancer: From molecular mechanisms to potential therapeutics. [PDF]
Kong R +5 more
europepmc +1 more source
Determinants of undesired α2-6-sialoside formation by PmST1 M144D.
Mozaneh F +4 more
europepmc +1 more source
Gangliosides in the 21st century: therapeutic prospects for the brain and spine. [PDF]
Magistretti PJ +5 more
europepmc +1 more source
Targeting Siglec-sialic acid checkpoint to reverse immune dysfunction mediated by plasmacytoid dendritic cells in myeloma. [PDF]
Ray A +9 more
europepmc +1 more source
The relationship of ST6GAL1 with clinicopathological and prognostic factors in breast carcinomas. [PDF]
Ömeroğlu E +4 more
europepmc +1 more source

